# Myxedema-related cardiac tamponade diagnosed by focused cardiac ultrasound (FoCUS): a case report

**Authors:** H. A. Nati-Castillo, Martin Ocampo-Posada, Wilfredo Antonio Rivera-Martínez, Fredy Lizarazo Davila, Alice Gaibor-Pazmiño, Marlon Rojas-Cadena, Juan S. Izquierdo-Condoy

PMC · DOI: 10.3389/fcvm.2026.1753361 · Frontiers in Cardiovascular Medicine · 2026-02-06

## TL;DR

A rare case of cardiac tamponade caused by severe hypothyroidism was diagnosed and treated using focused cardiac ultrasound, highlighting its value in emergency settings.

## Contribution

Demonstrates the practical utility of FoCUS in diagnosing cardiac tamponade due to myxedema in a resource-limited context.

## Key findings

- Focused cardiac ultrasound rapidly identified cardiac tamponade caused by severe hypothyroidism.
- Emergency pericardiocentesis improved the patient's condition immediately.
- Severe hypothyroidism is a rare but important cause of cardiac tamponade.

## Abstract

Pericardial effusion can progress to cardiac tamponade, a life-threatening condition in which clinical findings are often nonspecific and a complete Beck's triad is frequently absent. Focused cardiac ultrasound (FoCUS) provides rapid bedside recognition of tamponade physiology and can expedite definitive management. This case highlights its pragmatic value for promptly identifying tamponade in a rare endocrine etiology—severe hypothyroidism (myxedema)—particularly in resource-limited settings.

A 62-year-old man with a 6-month history of progressive lower-limb edema and exertional dyspnea deteriorated to dyspnea at rest and generalized anasarca. Examination showed myxedematous features, jugular venous distension, and muffled heart sounds. Bedside FoCUS demonstrated a massive circumferential pericardial effusion (∼28 mm in diastole) with right-atrial systolic and right-ventricular diastolic collapse, consistent with cardiac tamponade. Emergency pericardiocentesis drained 1,200 mL of serous fluid with immediate clinical improvement. Chest radiography obtained before drainage showed a “water-bottle” cardiac silhouette, and pericardial fluid studies were negative for infection and malignancy. Thyroid testing confirmed severe primary hypothyroidism (TSH 225 mIU/L; free T4 < 0.07 ng/dL). The patient was treated with monitored levothyroxine and had no recurrence of pericardial effusion on follow-up.

Severe hypothyroidism is an uncommon but clinically important cause of cardiac tamponade. In patients with unexplained cardiomegaly or hemodynamic compromise, early FoCUS—integrated with clinical assessment and targeted biochemical testing—can rapidly confirm tamponade physiology, accelerate lifesaving pericardiocentesis, and guide timely definitive therapy. FoCUS should be incorporated into routine emergency and critical-care workflows as an extension of the physical examination.

## Linked entities

- **Diseases:** hypothyroidism (MONDO:0005420), cardiac tamponade (MONDO:0001297), myxedema (MONDO:0009718)

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, POMC (proopiomelanocortin) [NCBI Gene 5443] {aka ACTH, CLIP, LPH, MSH, NPP, OBAIRH}, NPPB (natriuretic peptide B) [NCBI Gene 4879] {aka BNP, Iso-ANP}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}
- **Diseases:** reduced cardiac output (MESH:D002303), uremic (MESH:D006463), effusion (MESH:D000080324), infection (MESH:D007239), cardiovascular collapse (MESH:D002318), leukocytosis (MESH:D007964), diastolic collapse (MESH:D006337), pericardial disease (MESH:D008476), tachypnea (MESH:D059246), anemia (MESH:D000740), right (MESH:C535682), hypothyroidism (MESH:D007037), pheochromocytoma (MESH:D010673), cardiac tamponade (MESH:D002305), infectious (MESH:D003141), heart failure (MESH:D006333), thyroid dysfunction (MESH:D013959), cardiomegaly (MESH:D006332), malignancy (MESH:D009369), inferior vena cava plethora (MESH:C563013), dyspnea (MESH:D004417), anasarca (MESH:D004487), adrenal crisis (MESH:D000310), impaired ventricular filling (MESH:D018754), cardiopulmonary disorders (MESH:D006323), Myxedema (MESH:D009230), inflammatory (MESH:D007249), Wellens' syndrome (MESH:D013577), systemic autoimmune disease (MESH:D020274), fever (MESH:D005334), hypotension (MESH:D007022), neurological deficits (MESH:D009461), jugular venous distension (MESH:D005925), myxedematous facies (MESH:D019066), Pericardial effusion (MESH:D010490), Disorders of the pericardium (MESH:D009358), autoimmune (MESH:D001327), arrhythmias (MESH:D001145), gynecomastia (MESH:D006177), tachycardia (MESH:D013610), atrial systolic and right-ventricular diastolic collapse (MESH:D018487), venous distension (MESH:D014647)
- **Chemicals:** free thyroxine (-), Levothyroxine (MESH:D013974), creatinine (MESH:D003404), KOH (MESH:C029943), cortisol (MESH:D006854), oxygen (MESH:D010100)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12920499/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12920499/full.md

## References

25 references — full list in the complete paper: https://tomesphere.com/paper/PMC12920499/full.md

---
Source: https://tomesphere.com/paper/PMC12920499